ProShare Advisors LLC Sells 144,158 Shares of Genpact Limited $G

ProShare Advisors LLC lowered its holdings in Genpact Limited (NYSE:G) by 37.6% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 239,208 shares of the business services provider’s stock after selling 144,158 shares during the period. ProShare Advisors LLC’s holdings in Genpact were worth $7,781,000 as of its most recent SEC filing.

Other large investors have also recently added to or reduced their stakes in the company. Dimensional Fund Advisors LP raised its holdings in shares of Genpact by 12.0% during the first quarter. Dimensional Fund Advisors LP now owns 5,609,641 shares of the business services provider’s stock worth $208,965,000 after acquiring an additional 598,877 shares in the last quarter. First Trust Advisors LP grew its position in shares of Genpact by 10.2% in the first quarter. First Trust Advisors LP now owns 2,415,994 shares of the business services provider’s stock valued at $89,996,000 after purchasing an additional 222,899 shares during the last quarter. Temasek Holdings Private Ltd acquired a new position in shares of Genpact during the 1st quarter worth about $30,037,000. Pacer Advisors Inc. lifted its position in shares of Genpact by 40.7% during the 1st quarter. Pacer Advisors Inc. now owns 765,204 shares of the business services provider’s stock worth $28,504,000 after purchasing an additional 221,536 shares during the last quarter. Finally, Rice Hall James & Associates LLC boosted its stake in Genpact by 172.5% during the 1st quarter. Rice Hall James & Associates LLC now owns 704,124 shares of the business services provider’s stock valued at $26,229,000 after purchasing an additional 445,743 shares during the period. Institutional investors and hedge funds own 96.03% of the company’s stock.

Insider Buying and Selling at Genpact

In other news, SVP Anil Nanduru sold 6,191 shares of the business’s stock in a transaction that occurred on Wednesday, August 19th. The stock was sold at an average price of $37.03, for a total transaction of $229,252.73. Following the sale, the senior vice president directly owned 70,253 shares in the company, valued at approximately $2,601,468.59. The trade was a 8.10% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 1.58% of the company’s stock.

Genpact Stock Up 1.4%

NYSE G opened at $40.78 on Thursday. Genpact Limited has a twelve month low of $26.85 and a twelve month high of $48.64. The stock has a market cap of $6.82 billion, a PE ratio of 12.10, a PEG ratio of 1.07 and a beta of 0.53. The firm has a 50-day simple moving average of $36.35 and a 200 day simple moving average of $35.56. The company has a debt-to-equity ratio of 0.44, a quick ratio of 2.00 and a current ratio of 2.00.

Genpact (NYSE:G) last issued its quarterly earnings results on Tuesday, June 30th. The business services provider reported $1.00 earnings per share (EPS) for the quarter. The firm had revenue of $1.34 billion for the quarter. Genpact had a return on equity of 23.34% and a net margin of 11.04%. On average, research analysts forecast that Genpact Limited will post 3.66 EPS for the current year.

Genpact Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 23rd. Stockholders of record on Thursday, December 10th will be issued a dividend of $0.1875 per share. This represents a $0.75 annualized dividend and a dividend yield of 1.8%. The ex-dividend date of this dividend is Thursday, December 10th. Genpact’s dividend payout ratio (DPR) is presently 22.26%.

Analysts Set New Price Targets

A number of analysts have issued reports on the company. Wall Street Zen raised Genpact from a “hold” rating to a “buy” rating in a report on Saturday, October 3rd. TD Cowen increased their price objective on Genpact from $42.00 to $43.00 and gave the company a “buy” rating in a research report on Friday, August 7th. Weiss Ratings upgraded shares of Genpact from a “hold (c-)” rating to a “hold (c)” rating in a research note on Wednesday, October 14th. JPMorgan Chase & Co. boosted their target price on shares of Genpact from $40.00 to $45.00 and gave the stock a “neutral” rating in a research report on Friday, August 7th. Finally, Needham & Company LLC cut their target price on shares of Genpact from $50.00 to $45.00 and set a “buy” rating for the company in a research note on Friday, August 7th. Two equities research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $39.67.

Genpact Profile

Genpact (NYSE: G) is a global professional services and business process management company that helps organizations improve operations through digital transformation, data and analytics, artificial intelligence, and industry-specific expertise. The company combines technology with operational services to support clients across core business functions.

Its offerings include finance and accounting, procurement, supply chain management, customer experience, risk and compliance, insurance operations, and banking and capital markets services.